Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Oral Step-down Antibiotic Therapy Versus Continuing Intravenous Therapy for Uncomplicated Gram-negative Bacteraemia (the INVEST Trial)

NCT05199324 is registered in ClinicalTrials.gov with Tan Tock Seng Hospital as lead sponsor.

NCT NCT05199324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05199324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Oral Step-down Antibiotic Therapy Versus Continuing Intravenous Therapy for Uncomplicated Gram-negative Bacteraemia (the INVEST Trial)
Lead sponsor
Tan Tock Seng Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 3, 2022
Completion date
July 23, 2026
Enrollment
720 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

gram-negative bacteraemia